ADVINUS THERAPEUTICS PRIVATE LTD has a total of 23 patent applications. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Brazil. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ASLANIAN ROBERT G, CYTOPIA RES PTY LTD and LI YUN-LONG.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Brazil | 3 | |
#4 | Canada | 3 | |
#5 | China | 3 | |
#6 | Australia | 2 | |
#7 | Israel | 1 | |
#8 | United States | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Basu Sujay | 14 |
#2 | Ramdas Vidya | 12 |
#3 | Waman Yogesh | 12 |
#4 | Barawkar Dinesh | 12 |
#5 | Patel Meena | 11 |
#6 | Panmand Anil | 11 |
#7 | Palle Venkata | 10 |
#8 | Dave Bhavesh | 9 |
#9 | Koul Summon | 8 |
#10 | Deshpande Anil | 7 |
Publication | Filing date | Title |
---|---|---|
ZA201106695B | Substituted fused pyrimidine compounds | |
CA2810625A1 | Purine compounds as prodrugs of a2b adenosine receptor antagonists, their process and medicinal applications | |
WO2011095997A1 | Benzamide compounds as glucokinase activators and their pharmaceutical application | |
WO2011080755A1 | Fused nitrogen heterocyclic compounds, process of preparation and uses thereof | |
WO2010103547A2 | Substituted fused pyrimidine compounds | |
BRPI0909157A2 | heterocyclic compounds as adenosine receptor antagonists | |
CN101827832A | Acetamide derivatives as glucokinase activators, their process and medicinal applications | |
EP2155720A1 | Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application | |
CN101622231A | 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application |